1. Home
  2. MSGS vs BLCO Comparison

MSGS vs BLCO Comparison

Compare MSGS & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSGS
  • BLCO
  • Stock Information
  • Founded
  • MSGS 1879
  • BLCO 1853
  • Country
  • MSGS United States
  • BLCO Canada
  • Employees
  • MSGS N/A
  • BLCO N/A
  • Industry
  • MSGS Services-Misc. Amusement & Recreation
  • BLCO Ophthalmic Goods
  • Sector
  • MSGS Consumer Discretionary
  • BLCO Health Care
  • Exchange
  • MSGS Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • MSGS 4.9B
  • BLCO 4.9B
  • IPO Year
  • MSGS N/A
  • BLCO 2022
  • Fundamental
  • Price
  • MSGS $208.46
  • BLCO $13.90
  • Analyst Decision
  • MSGS Buy
  • BLCO Hold
  • Analyst Count
  • MSGS 5
  • BLCO 13
  • Target Price
  • MSGS $252.60
  • BLCO $15.83
  • AVG Volume (30 Days)
  • MSGS 245.6K
  • BLCO 753.2K
  • Earning Date
  • MSGS 08-12-2025
  • BLCO 07-30-2025
  • Dividend Yield
  • MSGS N/A
  • BLCO N/A
  • EPS Growth
  • MSGS N/A
  • BLCO N/A
  • EPS
  • MSGS 0.20
  • BLCO N/A
  • Revenue
  • MSGS $1,062,514,000.00
  • BLCO $4,829,000,000.00
  • Revenue This Year
  • MSGS N/A
  • BLCO $6.99
  • Revenue Next Year
  • MSGS $5.28
  • BLCO $5.46
  • P/E Ratio
  • MSGS $1,045.43
  • BLCO N/A
  • Revenue Growth
  • MSGS 14.64
  • BLCO 11.94
  • 52 Week Low
  • MSGS $173.26
  • BLCO $10.45
  • 52 Week High
  • MSGS $237.99
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • MSGS 58.88
  • BLCO 62.52
  • Support Level
  • MSGS $204.11
  • BLCO $13.59
  • Resistance Level
  • MSGS $211.43
  • BLCO $14.26
  • Average True Range (ATR)
  • MSGS 4.20
  • BLCO 0.45
  • MACD
  • MSGS -0.05
  • BLCO 0.02
  • Stochastic Oscillator
  • MSGS 65.38
  • BLCO 77.00

About MSGS Madison Square Garden Sports Corp. (New)

Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: